| Autor: |
Dieter RS; Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. rdieter@mail.mcw.edu, Schmidt WS, Pacanowski JP Jr, Jaff MR |
| Jazyk: |
angličtina |
| Zdroj: |
Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2005 May; Vol. 3 (3), pp. 413-22. |
| DOI: |
10.1586/14779072.3.3.413 |
| Abstrakt: |
Renal artery disease is the most common cause of potentially curable secondary hypertension, with atherosclerosis as the major cause of renal artery stenosis. Fibromuscular dysplasia is a less common cause of renal artery stenosis and is most frequently observed in premenopausal women. Renal artery stenosis is likely to be underappreciated and is more common in patients with other vascular disease (e.g., coronary or peripheral arterial disease). The diagnosis of renal artery stenosis requires a high clinical index of suspicion as well as an appropriate imaging strategy, with currently effective diagnostic modalities including magnetic resonance imaging, computed tomography and renal artery duplex ultrasonography. The current treatment of choice for atherosclerotic renal artery stenosis is balloon angioplasty and secondary stenting, whereas angioplasty alone is the treatment for renal artery stenosis secondary to fibromuscular dysplasia. Expected outcomes following revascularization include improved blood pressure control and possibly renal preservation. Ongoing studies will hopefully identify patient characteristics that will achieve the most benefit from percutaneous revascularization as well as the impact of percutaneous revascularization with drug-eluting stents and embolic protection devices. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
